- Shares of Can-Fite BioPharma Ltd. CANF surged 30.5% after the company announced its strategic partnership with Univo to develop cannabinoid-based products is ongoing.
- Shares of Immunomedics, Inc. IMMU gained 5.7% after the company announced that the FDA had accepted for filing the company's BLA seeking accelerated approval of sacituzumab govitecan to treat metastatic triple-negative breast cancer.
- Shares of Spring Bank Pharmaceuticals, Inc. SBPH declined 66.8% after the company reported that it has stopped the dosing of inarigivir patients in Phase 2 program.
- Shares of QIAGEN N.V. QGEN declined 20.6% after the company announced that it would not be acquired and will stay a standalone business.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
QIAGEN N.V. (QGEN) : Free Stock Analysis Report
Immunomedics, Inc. (IMMU) : Free Stock Analysis Report
Can-Fite Biopharma Ltd (CANF) : Free Stock Analysis Report
Spring Bank Pharmaceuticals, Inc. (SBPH) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research